Press Review

Key Takeaways Top story: A study reveals shared brain patterns in autism and ADHD, generating new discussions about diagnosis and support. Teens are warned against relying on AI chatbots as substitutes for qualified mental health care. Long-term stimulant tolerance may…

Key Takeaways A Finnish study finds that an adult ADHD diagnosis is linked to significantly lower antidepressant use, highlighting potential implications for treatment strategies. This ADHD press review for 21 November 2025 details cascading impacts of ADHD medication shortages and…

Key Takeaways Study finds many young children with ADHD are medicated earlier than recommended. AI productivity apps tailored for neurodivergent minds are simplifying complex workflows. ADHD entrepreneurs detail business systems that help prevent burnout and boost sustainability. Extended testing time…

Key Takeaways Top story: AI systems now detect ADHD with over 90% accuracy using visual analysis, marking a significant advance in early identification. Girls’ ADHD symptoms are frequently overlooked in routine screenings, often leading to delayed support. Daily screen time…

Key Takeaways A new study reports an AI model now detects adult ADHD with 90% accuracy using visual processing. The Press Review for 2 November 2025 highlights diagnostic gaps for women and introduces new practical tools supporting neurodivergent professionals. Top…

Key Takeaways On 1 November 2025, ADHD news and developments focus on CTx-1301, a once-daily ADHD medication showing strong results in Phase 3 trials. New Zealand eases access to diagnosis, and new studies highlight gender gaps and trends in treatment….

Key Takeaways A new hybrid parent training program integrates proven ADHD strategies with a dedicated smartphone app, supporting families navigating ADHD neurodivergence. Today’s review highlights new data on preschool ADHD medication use, AI-driven executive function tools, and entrepreneurial approaches to…

Key Takeaways On 30 October 2025, today’s Press Review highlights a significant advance in ADHD news and developments with the CTx-1301 Phase 3 trial indicating the potential for once-daily dosing in children. Top story: The CTx-1301 Phase 3 trial reports…

Key Takeaways Top story: New Zealand enables GPs and nurse practitioners to diagnose ADHD, promising faster, more flexible access. Study finds women with ADHD often face longer diagnostic delays and more severe outcomes. AI-powered assistant launched to support neurodivergent professionals…

Key Takeaways On 28 October 2025, the ADHD news review highlights new research revealing that insomnia has a major impact on life quality for adults with ADHD. Insomnia significantly reduces life quality in adults with ADHD, according to new research….